(2026). Assessing the real-world safety of vutrisiran for transthyretin-mediated amyloidosis with polyneuropathy: Based on WHO-VigiAccess and FAERS databases. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Assessing the Real-world Safety of Vutrisiran for Transthyretin-mediated Amyloidosis with Polyneuropathy: Based on WHO-VigiAccess and FAERS Databases."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Assessing the Real-world Safety of Vutrisiran for Transthyretin-mediated Amyloidosis with Polyneuropathy: Based on WHO-VigiAccess and FAERS Databases."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.